The type and quantity of dietary fat and carbohydrate alter faecal microbiome and short-chain fatty acid excretion in a metabolic syndrome 'at-risk' population

International Journal of Obesity

Volumn 37, Issue 2, 2013, Pages 216-223

  Fava, F ^a,b   Gitau, R ^a   Griffin, B A ^c   Gibson, G R ^a   Tuohy, K M ^a,b   Lovegrove, J A ^a  

^a UNIVERSITY OF READING   (United Kingdom)

^b RESEARCH AND INNOVATION CENTRE   (Italy)

^c UNIVERSITY OF SURREY   (United Kingdom)

Author keywords

dietary carbohydrate; dietary fat; gut microbiota; RISCK; SCFA

Indexed keywords

CHOLESTEROL; GLUCOSE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MONOUNSATURATED FATTY ACID; SHORT CHAIN FATTY ACID;

ADULT; ARTICLE; BACTERIAL COUNT; BACTEROIDES; BIFIDOBACTERIUM; BODY WEIGHT; CARBOHYDRATE INTAKE; CONTROLLED STUDY; FAECALIBACTERIUM PRAUSNITZII; FAT INTAKE; FECES; FEMALE; GLYCEMIC INDEX; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MICROBIOME; PLASMA; PRIORITY JOURNAL;

ADULT; AGED; BACTEROIDES; BIFIDOBACTERIUM; BLOOD GLUCOSE; CHOLESTEROL; CHROMATOGRAPHY, GAS; COLON; DIET; DIETARY CARBOHYDRATES; DIETARY FATS; FATTY ACIDS, MONOUNSATURATED; FATTY ACIDS, VOLATILE; FECES; FEMALE; FERMENTATION; GREAT BRITAIN; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; RISK ASSESSMENT; VULNERABLE POPULATIONS;

BACTERIA (MICROORGANISMS); BACTEROIDES; BACTEROIDETES; BIFIDOBACTERIUM; FAECALIBACTERIUM PRAUSNITZII; FIRMICUTES;

EID: 84873724959     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/ijo.2012.33     Document Type: Article

References (44)

1. The NHS Information Centre, Lifestyles Statistics (10 February 2010). The Health and Social Care Information Centre. Statistics on obesity, physical activity and diet: England, 2010. Available at http://www.ic.nhs.uk/webfiles/ publications/opad10/Statistics-on-Obesity-Physical-Activity-and-Diet-England- 2010.pdf.
2. Balkau B, Charles MA, Drivsholm T, Borch-Johnsen K, Wareham N, Yudkin JS et al. Frequency of the WHO metabolic syndrome in European cohorts, and an alternative definition of an insulin resistance syndrome. Diabetes Metab 2002; 28: 364-376.
3. Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595-1607.
4. Stern MP. Do non-insulin-dependent diabetes mellitus and cardiovascular disease share common antecedents? Ann Intern Med 1996; 124: 110-116.
5. Gardner CD, Kraemer HC. Monounsaturated versus polyunsaturated dietary fat and serum lipids. A meta-analysis. Arterioscler Thromb Vasc Biol 1995; 15: 1917-1927.
6. Laaksonen M, Prättälä R, Karisto A. Patterns of unhealthy behaviour in Finland. Eur J Public Health 2001; 11: 294-300.
7. Conterno L, Fava F, Viola R, Tuohy KM. Obesity and the gut microbiota: does up-regulating colonic fermentation protect against obesity and metabolic disease? Genes Nutr 2011; 6: 241-260.
8. Ley RE. Obesity and the human microbiome. Curr Opin Gastroenterol 2010; 26: 5-11.
9. Cani PD, Amar J, Iglesias MA, Poggi M, Knauf C, Bastelica D et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 2007; 56: 1761-1772.
10. Dumas ME, Barton RH, Toye A, Cloarec O, Blancher C, Rothwell A et al. Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice. Proc Natl Acad Sci USA 2006; 103: 12511-12516.
11. Murphy EF, Cotter PD, Healy S, Marques TM, O'Sullivan O, Fouhy F et al. Composition and energy harvesting capacity of the gut microbiota: relationship to diet, obesity and time in mouse models. Gut 2010; 59: 1635-1642.
12. Ley RE, Bäckhed F, Turnbaugh P, Lozupone CA, Knight RD, Gordon JI. Obesity alters gut microbial ecology. Proc Natl Acad Sci USA 2005; 102: 11070-11075.
13. Waldram A, Holmes E, Wang Y, Rantalainen M, Wilson ID, Tuohy KM et al. Top-down systems biology modeling of host metabotype-microbiome associations in obese rodents. J Proteome Res 2009; 8: 2361-2375.
14. Turnbaugh PJ, Bäckhed F, Fulton L, Gordon JI. Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome. Cell Host Microbe 2008; 3: 213-223.
15. Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 2006; 444: 1027-1031.
16. Ley RE, Turnbaugh PJ, Klein S, Gordon JI. Microbial ecology: human gut microbes associated with obesity. Nature 2006; 444: 1022-1023.
17. Duncan SH, Belenguer A, Holtrop G, Johnstone AM, Flint HJ, Lobley GE. Reduced dietary intake of carbohydrates by obese subjects results in decreased concentrations of butyrate and butyrate-producing bacteria in feces. Appl Environ Microbiol 2007; 73: 1073-1078.
18. Brinkworth GD, Noakes M, Clifton PM, Bird AR. Comparative effects of very low-carbohydrate, high-fat and high-carbohydrate, low-fat weight-loss diets on bowel habit and faecal short-chain fatty acids and bacterial populations. Br J Nutr 2009; 101: 1493-1502.
19. Schwiertz A, Taras D, Schäfer K, Beijer S, Bos NA, Donus C et al. Microbiota and SCFA in lean and overweight healthy subjects. Obesity 2010; 18: 190-195.
20. Jackson KG, Taylor GR, Clohessy AM, Williams CM. The effect of the daily intake of inulin on fasting lipid, insulin and glucose concentrations in middle-aged men and women. Br J Nutr 1999; 82: 23-30.
21. Balcázar-Muñ oz BR, Mart́nez-Abundis E, Gonzá lez-Ortiz M. Effect of oral inulin administration on lipid profile and insulin sensitivity in subjects with obesity and dyslipidemia. Rev Med Chil 2003; 131: 597-604.
22. Cani PD, Neyrinck AM, Fava F, Knauf C, Burcelin RG, Tuohy KM et al. Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia. Diabetologia 2007; 50: 2374-2383.
23. Cani PD, Possemiers S, Van de Wiele T, Guiot Y, Everard A, Rottier O et al. Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut 2009; 58: 1091-1103.
24. Wang Z, Klipfell E, Bennett BJ, Koeth R, Levison BS, Dugar B et al. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature 2011; 472: 57-63.
25. Jebb SA, Lovegrove JA, Griffin BA, Frost GS, Moore CS, Chatfield MD et al. Effect of changing the amount and type of fat and carbohydrate on insulin sensitivity and cardiovascular risk: the RISCK (Reading, Imperial, Surrey, Cambridge, and Kings) trial. Am J Clin Nutr 2010; 92: 748-758.
26. Moore C, Gitau R, Goff L, Lewis FJ, Griffin MD, Chatfield MD et al. Successful manipulation of the quality and quantity of fat and carbohydrate consumed by free-living individuals using a food exchange model. J Nutr 2009; 139: 1534-1540.
27. Jebb SA. Dietary determinants of obesity. Obes Rev 2007; 8 (Suppl 1): 93-97.
28. National Diet and Nutrition Survey (NDNS) 2004. Available from: http://tna. europarchive.org/20110116113217/. http://www.food.gov.uk/science/ dietarysur veys/ndnsdocuments/.
29. National Food Survey (NFS). 1997-2000. Available from: http://tna.europarchive. org/20110116113217/. http://www.food.gov.uk/science/ surveillance/.
30. Tuohy KM, Kolida S, Lustenberger AM, Gibson GR. The prebiotic effects of biscuits containing partially hydrolysed guar gum and fructo-oligosaccharides-a human volunteer study. Br J Nutr 2001; 86: 341-348.
31. Franks AH, Harmsen HJ, Raangs GC, Jansen GJ, Schut F, Welling GW. Variations of bacterial populations in human feces measured by fluorescent in situ hybridization with group-specific 16S rRNA-targeted oligonucleotide probes. Appl Environ Microbiol 1998; 64: 3336-3345.
32. Manz W, Amann R, Ludwig W, Vancanneyt M, Schleifer KH. Application of a suite of 16S rRNA-specific oligonucleotide probes designed to investigate bacteria of the phylum cytophaga-flavobacter-bacteroides in the natural environment. Microbiology 1996; 142: 1097-1106.
33. Hold GL, Schwiertz A, Aminov RI, Blaut M, Flint HJ. Oligonucleotide probes that detect quantitatively significant groups of butyrate-producing bacteria in human feces. Appl Environ Microbiol 2003; 69: 4320-4324.
34. Langendijk PS, Schut F, Jansen GJ, Raangs GC, Kamphuis GR, Wilkinson MH et al. Quantitative fluorescence in situ hybridization of Bifidobacterium spp. with genus-specific 16S rRNA-targeted probes and its application in fecal samples. Appl Environ Microbiol 1995; 61: 3069-3075.
35. Harmsen HJ, Wildeboer-Veloo AC, Grijpstra J, Knol J, Degener JE, Welling GW. Development of 16S rRNA-based probes for the Coriobacterium group and the Atopobium cluster and their application for enumeration of Coriobacteriaceae in human feces from volunteers of different age groups. Appl Environ Microbiol 2000; 66: 4523-4527.
36. Harmsen HJM, Elfferich P, Schut F, Welling GW. A 16S rRNA-targeted probe for detection of lactobacilli and enterococci in fecal samples by fluorescent in situ hybridization. Microb Ecol Health Dis 1999; 11: 3-12.
37. Franks AH, Harmsen HJ, Raangs GC, Jansen GJ, Schut F, Welling GW. Variations of bacterial populations in human feces measured by fluorescent in situ hybridization with group-specific 16S rRNA-targeted oligonucleotide probes. Appl Environ Microbiol 1998; 64: 3336-3345.
38. Icgen B, Moosa S, Harrison ST. A study of the relative dominance of selected anaerobic sulfate-reducing bacteria in a continuous bioreactor by fluorescence in situ hybridization. Microb Ecol 2007; 53: 43-52.
39. Ootsubo M, Shimizu T, Tanaka R, Sawabe T, Tajima K, Yoshimizu M et al. Oligonucleotide probe for detecting Enterobacteriaceae by in situ hybridization. J Appl Microbiol 2002; 93: 60-68.
40. Bäckhed F, Ley RE, Sonnenburg JL, Peterson DA, Gordon JI. Host-bacterial mutualism in the human intestine. Science 2005; 307: 1915-1920.
41. Chapman RW, Sillery JK, Graham MM, Saunders DR. Absorption of starch by healthy ileostomates: effect of transit time and of carbohydrate load. Am J Clin Nutr 1985; 41: 1244-1248.
42. Kolida S, Saulnier DM, Gibson GR. Gastrointestinal microflora: probiotics. Adv Appl Microbiol 2006; 59: 187-219.
43. Tuohy KM, Rouzaud GC, Brü ck WM, Gibson GR. Modulation of the human gut microflora towards improved health using prebiotics-assessment of efficacy. Curr Pharm Des 2005; 11: 75-90.
44. Vogt JA, Wolever TM. Fecal acetate is inversely related to acetate absorption from the human rectum and distal colon. J Nutr 2003; 133: 3145-3148.